Plant-derived bioactive peptides and protein hydrolysates for managing MAFLD: A systematic review of in vivo effects
2025
Santos-Sánchez, Guillermo | Cruz-Chamorro, Iván | Agencia Estatal de Investigación (España) | Ministerio de Ciencia, Innovación y Universidades (España) | Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]
Metabolic dysfunction-associated fatty liver disease (MAFLD) represents a growing health concern worldwide. Among the pursuit of therapeutic interventions, interest in natural bioactive compounds has intensified because of their potential hepatoprotective effects.
显示更多 [+] 显示较少 [-]This systematic review aims to evaluate the impact of plant-derived hydrolysates and peptides on MAFLD through the current literatures, encompassing their mechanisms of action. Key outcomes evaluated included changes in liver enzymes, liver lipid content, inflammation markers, and histopathological improvements.
显示更多 [+] 显示较少 [-]Preliminary findings suggest a potential beneficial effect of plant-derived hydrolysates and peptides on the improvement of MAFLD-related parameters, with mechanisms implicating antioxidant, anti-inflammatory, and lipid-lowering properties. This review highlights emerging evidence supporting the potential therapeutic role of plant-derived hydrolysates and peptides in the management of MAFLD. However, more well-designed clinical trials with larger sample sizes and longer durations are warranted to elucidate their efficacy, optimal dose, and long-term safety.
显示更多 [+] 显示较少 [-]G.S.-S. was supported by Ministerio de Ciencia e Innovación, Gobierno de España (JDC2022-048411-I).
显示更多 [+] 显示较少 [-]Peer reviewed
显示更多 [+] 显示较少 [-]